Pembrolizumab Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
Hepatocellular CarcinomaRadiotherapyPembrolizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled1 locationNCT06389422
Recruiting
Phase 3
Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
Neoadjuvant TherapyHead and Neck Squamous Cell CarcinomaPembrolizumab
Beijing Tongren Hospital272 enrolled1 locationNCT06102395